GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that the U.S. Patent and Trademark Office ...

Health chiefs have issued an alert after a fresh case of a killer strain of mpox has been detected in Britain. It is the first not linked to travel abroad.

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent 09.04.2025 / 15:07 CET/CEST The issuer is solely responsible ...

The COVID-19 pandemic highlighted the critical need for clear communication, robust scientific research, and proactive ...

Infectious diseases are becoming more frequent, more severe, and harder to control in our closely connected world. Viruses ...

In summary, the study shows exciting promise for a simple, plant-based solution to a complex global problem. By using natural ...

Five years after the COVID-19 pandemic, funding for Ralph Baric's lab, which developed the first COVID treatment, is up in ...

Researchers had known that there was something odd about the development of MS, and attributed it to the so-called hygiene ...

New research shows how small shifts in the molecular makeup of a virus can profoundly alter its fate. These shifts could turn ...

Reducing the maternal mortality rate due to postpartum haemorrhage depends on the ability of health-care teams to identify pregnant women at higher risk of bleeding, to timely and accurately detect ...

The link between the virus and disease has opened new ways to consider how MS might be treated. Antiviral drugs are being investigated in clinical trials as possible add-ons to the standard MS ...

Viral pneumonia can sometimes stem from viruses that include the flu, common cold, COVID-19 and respiratory syncytial virus (RSV), according to Cleveland Clinic. This type of pneumonia typically ...